Quick Answer
Oruka Therapeutics, Inc. reported Shares Outstanding of 48.72 million shares for fiscal year 2025.
Oruka Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 48.72M | +30.1% |
| 2024 | 37.44M | +1070.8% |
| 2024 | 3.20M | -77.9% |
| 2023 | 14.50M | +0.6% |
| 2022 | 14.41M | +0.0% |
| 2021 | 14.41M | +50.9% |
| 2020 | 9.55M | +499.0% |
| 2019 | 1.59M | +106.1% |
| 2018 | 773,558 | -93.4% |
| 2017 | 11.78M | +29.6% |
| 2016 | 9.08M | +0.3% |
| 2015 | 9.05M | +199.6% |
| 2014 | 3.02M | -80.7% |
| 2013 | 15.69M | +489.6% |
| 2012 | 2.66M | +31.0% |
| 2011 | 2.03M | -77.0% |
| 2010 | 8.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 48.38M | +38.2% | +29.2% |
| June 30, 2025 | 37.45M | +158.2% | +0.0% |
| March 31, 2025 | 37.44M | +158.2% | +0.0% |
| December 31, 2024 | 37.44M | +158.2% | +7.0% |
| September 30, 2024 | 35.00M | +142.9% | +141.3% |
| June 30, 2024 | 14.51M | +0.7% | +0.0% |
| March 31, 2024 | 14.50M | +0.6% | +353.4% |
| January 31, 2024 | 3.20M | — | -77.9% |
- Oruka Therapeutics, Inc. showed an increase of +30.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Oruka Therapeutics, Inc.’s shares outstanding has grown by 451.5% (from 8.83 million shares to 48.72 million shares).
- The most recent figure is from Oruka Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: